Hagen Heidi 4

4 · Vericel Corp · Filed Oct 21, 2024

Form 4

Period: 2024-10-17

Director

Transactions

Exercise/Conversion
Common Stock
2024-10-17$3.74/sh+6,000$22,440→ 28,650 total
Exercise/Conversion
Common Stock
2024-10-17$3.74/sh+4,000$14,960→ 22,650 total
Exercise/Conversion
Stock Option (Right to Buy)
2024-10-17+6,000→ 9,000 total
Exercise: $3.74→ Common Stock (6,000 underlying)
Exercise/Conversion
Stock Option (Right to Buy)
2024-10-17+4,000→ 0 total
Exercise: $3.74→ Common Stock (4,000 underlying)

Footnotes (4)

[F1]The Reporting Person has elected to exercise and hold these shares at this time.
[F2]These options, representing the right to purchase 4,000 shares, became exercisable in three installments, contingent upon continued service to the Company, with the first vesting date on March 20, 2015, which was the date on which the option was granted, and the final vesting date on May 1, 2015.
[F3]These options, which were awarded on March 20, 2015, would otherwise expire and become forfeitable on March 20, 2025.
[F4]These options, representing the right to purchase 15,000 shares, were originally granted on March 20, 2015, with 624 shares becoming exercisable on the grant date, 312 shares becoming exercisable on March 31, 2015, and the remainder becoming exercisable in equal monthly installments, contingent upon continued service to the Company, from April 30, 2015 through December 31, 2017.

Documents

1 file